Literature DB >> 3288478

The dementias of Parkinson's disease: prevalence, characteristics, neurobiology, and comparison with dementia of the Alzheimer type.

J L Cummings1.   

Abstract

Overt dementia occurs in 40% of Parkinson's disease (PD) patients, but neuropsychological testing indicates that mental status changes are ubiquitous. The characteristics of the intellectual changes in PD are those of subcortical dementia and include impaired recall, visuospatial disturbances, executive deficits, bradyphrenia, and depression. Language function is largely uninvolved. These features contrast with the neuropsychological abnormalities of dementia of the Alzheimer type (DAT) where language and memory encoding are prominently affected and depression is rare. The dopaminergic deficit of PD is complicated in some patients by a cholinergic deficit and in others by DAT. Several dementia syndromes exist within PD, reflecting the superimposition of different types of pathologies and multiple neurotransmitter deficits.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3288478

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  13 in total

1.  Rivastigmine for dementia associated with Parkinson's disease.

Authors:  John Morgan; Kapil D Sethi
Journal:  Curr Neurol Neurosci Rep       Date:  2005-07       Impact factor: 5.081

2.  Cognitive and SPECT characteristics predict progression of Parkinson's disease in newly diagnosed patients.

Authors:  Kathy Dujardin; Luc Defebvre; Alain Duhamel; Pascal Lecouffe; Pascal Rogelet; Marc Steinling; Alain Destée
Journal:  J Neurol       Date:  2004-11       Impact factor: 4.849

3.  Neurofibrillary changes confined to the entorhinal region and an abundance of cortical amyloid in cases of presenile and senile dementia.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

4.  Neuropsychological outcome after unilateral pallidotomy for the treatment of Parkinson's disease.

Authors:  G M Rettig; M K York; E C Lai; J Jankovic; J K Krauss; R G Grossman; H S Levin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-09       Impact factor: 10.154

5.  The contribution of executive control on verbal-learning impairment in patients with Parkinson's disease with dementia and Alzheimer's disease.

Authors:  Timothy J O'Brien; Virginia Wadley; Anthony P Nicholas; Natividad P Stover; Ray Watts; H Randall Griffith
Journal:  Arch Clin Neuropsychol       Date:  2009-07-08       Impact factor: 2.813

6.  The cognitive side of essential tremor: what are the therapeutic implications?

Authors:  Sarah C Janicki; Stephanie Cosentino; Elan D Louis
Journal:  Ther Adv Neurol Disord       Date:  2013-11       Impact factor: 6.570

Review 7.  Cognitive deficits and psychosis in Parkinson's disease: a review of pathophysiology and therapeutic options.

Authors:  Caroline H Williams-Gray; Thomas Foltynie; Simon J G Lewis; Roger A Barker
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

8.  Balanced dopamine is critical for pattern completion during associative memory recall.

Authors:  Fei Li; L Phillip Wang; Xiaoming Shen; Joe Z Tsien
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

9.  Cognitive impairment and dementia in Parkinson's disease: clinical features, diagnosis, and management.

Authors:  Joana Meireles; João Massano
Journal:  Front Neurol       Date:  2012-05-25       Impact factor: 4.003

10.  A clinical profile of patients with Parkinson's disease and psychosis.

Authors:  B R Amar; Ravi Yadav; Y C Janardhan Reddy; Pramod Kumar Pal
Journal:  Ann Indian Acad Neurol       Date:  2014-04       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.